KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Accounts Payables (2016 - 2026)

Eli Lilly filings provide 18 years of Accounts Payables readings, the most recent being $5.0 billion for Q1 2026.

  • On a quarterly basis, Accounts Payables rose 46.11% to $5.0 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $5.0 billion, a 46.11% increase, with the full-year FY2025 number at $5.4 billion, up 66.58% from a year prior.
  • Accounts Payables hit $5.0 billion in Q1 2026 for Eli Lilly, down from $5.4 billion in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $5.4 billion in Q4 2025 to a low of $1.4 billion in Q1 2022.
  • Median Accounts Payables over the past 5 years was $2.6 billion (2023), compared with a mean of $2.9 billion.
  • Biggest five-year swings in Accounts Payables: decreased 12.58% in 2022 and later soared 66.58% in 2025.
  • Eli Lilly's Accounts Payables stood at $1.9 billion in 2022, then soared by 34.61% to $2.6 billion in 2023, then rose by 24.25% to $3.2 billion in 2024, then skyrocketed by 66.58% to $5.4 billion in 2025, then fell by 6.51% to $5.0 billion in 2026.
  • The last three reported values for Accounts Payables were $5.0 billion (Q1 2026), $5.4 billion (Q4 2025), and $4.3 billion (Q3 2025) per Business Quant data.